Registry of Catheter Intervention in Pulmonary Embolism

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

300 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-09-18

Study Completion Date

2030-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Multicenter longitudinal observational ambispective (retrospective cases from 2014 and prospective from 2018 onwards) cohort study. The registry recruits a series of consecutive patients admitted for moderate-high risk or high-risk pulmonary embolism (according to 2019 European Society of Cardiology guidelines) treated invasively. This study aims to describe the acute management of the safety and effectiveness of different percutaneous interventions for acute pulmonary embolism.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Catheter-Directed Pulmonary Reperfusion in Treatment of Pulmonary Embolism Patients

NCT04911192

Pulmonary Embolism

UNKNOWN NA

Surgery in Pulmonary Embolisms

NCT06070129

Pulmonary Embolism

NOT_YET_RECRUITING

Institutional Registry of Thromboembolic Disease

NCT01372514

Thromboembolism Venous Thromboembolism Pulmonary Embolism

UNKNOWN

Thrombolytic and Interventional Treatment of Pulmonary Embolism

NCT03886194

Pulmonary Embolism

UNKNOWN NA

An Observational Study About Adverse Outcomes in Acute Pulmonary Embolism Patients

NCT05481242

Pulmonary Embolism and Thrombosis Deterioration, Clinical

ACTIVE_NOT_RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Pulmonary Embolism Pulmonary Embolism Acute Massive Pulmonary Embolism Acute Pulmonary Embolism and Thrombosis Pulmonary Thromboembolisms

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients (aged 18 years old or older)
* confirmed diagnosis of acute PE (on computed tomography or echocardiogram plus pulmonary angiography)
* high-risk PE or intermediate-high risk according to ESC risk stratification in the 2019 guidelines (briefly, elevated cardiac biomarkers \[troponin or N-terminal pro-B-type natriuretic peptide\], and right ventricle to left ventricle ratio \> 0.9 \[on computed tomography or echocardiogram\], and PE severity index III to IV or simplified PE severity index=1
* eligibility for catheter-directed intervention